We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$83.7B
AUM Growth
-$1.57B
Cap. Flow
-$3.66B
Cap. Flow %
-4.37%
Top 10 Hldgs %
8.74%
Holding
5,820
New
545
Increased
1,802
Reduced
1,597
Closed
679

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$365M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$307M
3
ADBE icon
Adobe
ADBE
+$250M
4
NVDA icon
NVIDIA
NVDA
+$242M
5
CRM icon
Salesforce
CRM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 13.14%
2 Financials 9.37%
3 Healthcare 7.49%
4 Consumer Discretionary 6.79%
5 Communication Services 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFIB
5476
DELISTED
Acutus Medical Inc
AFIB
-11,765
Closed -$13K
CONX
5477
DELISTED
CONX Corp. Class A Common Stock
CONX
-2,256,807
Closed -$22.3M
PXD
5478
DELISTED
Pioneer Natural Resource Co.
PXD
-50,141
Closed -$11.5M
FUV
5479
DELISTED
Arcimoto, Inc. Common Stock
FUV
-2,146
Closed -$140K
SOLO
5480
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
-47,649
Closed -$64K
LIBYU
5481
DELISTED
Liberty Resources Acquisition Corp. Unit
LIBYU
-100,000
Closed -$1.01M
CYT
5482
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-58,529
Closed -$175K
SNCE
5483
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
-3,900
Closed -$157K
FAZE
5484
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
-53,192
Closed -$530K
GOEV
5485
DELISTED
Canoo Inc. Class A Common Stock
GOEV
-1,404
Closed -$1.2M
BFX
5486
CALL
DELISTED
BowFlex Inc.
BFX
-17,300
Closed -$30K
BFX
5487
DELISTED
BowFlex Inc.
BFX
-365,268
Closed -$639K
CRGE
5488
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
-22,004
Closed -$105K
ROVR
5489
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
-24,739
Closed -$93K
LCA
5490
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
-1,580,295
Closed -$15.5M
SIEN
5491
DELISTED
Sientra, Inc.
SIEN
-80,701
Closed -$676K
GMBL
5492
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
-3
Closed -$47K
CHEAU
5493
DELISTED
Chenghe Acquisition Co. Unit
CHEAU
-33,333
Closed -$335K
THRX
5494
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
-10,412
Closed -$58K
CPTK
5495
DELISTED
Crown PropTech Acquisitions
CPTK
-211,023
Closed -$2.08M
NVTA
5496
DELISTED
Invitae Corporation
NVTA
-3,873,237
Closed -$9.45M
ORTX
5497
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-22,627
Closed -$132K
SRC
5498
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-39,402
Closed -$1.49M
SRT
5499
DELISTED
Startek Inc.
SRT
-15,027
Closed -$43K
LVOX
5500
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
-91,402
Closed -$152K

Similar funds

D.E. Shaw & Co's Q3 2022 Portfolio in Review

As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.

  • D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
  • D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
  • D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
  • D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
  • D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
  • D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
  • D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.